Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2022-08-15

Exempt reporting adviser since 2021 · other (specify)

As an employer

$526.9m reported value -11.7% vs Q1 2022
50positions
65.7%in top 10
14 new 17 added 12 reduced 23 sold out vs Q1 2022

Options: 7 call positions ($408.0m notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 798,610 $52.8m10.01% 10.01% ReducedShares held: Q3 2021 1.3m, Q4 2021 1.1m, Q1 2022 836.8k, Q2 2022 798.6k -38.2k -38,207 -4.6%
2 JOHNSON & JOHNSON COM JNJ JNJ 276,451 $49.1m9.31% 9.31% ReducedShares held: Q3 2021 238.9k, Q4 2021 155.1k, Q1 2022 295.0k, Q2 2022 276.5k -18.6k -18,572 -6.3%
3 ELI LILLY & CO COM LLY LLY 132,250 $42.9m8.14% 8.14% AddedShares held: Q3 2021 348.5k, Q4 2021 159.7k, Q1 2022 70.3k, Q2 2022 132.2k +62.0k +61,955 88.1%
4 SANOFI SPONSORED ADR SNY SNY 846,215 $42.3m8.04% 8.04% ReducedShares held: Q3 2021 843.4k, Q4 2021 1.1m, Q1 2022 972.4k, Q2 2022 846.2k -126.2k -126,200 -13.0%
5 ABBVIE INC COM ABBV ABBV 218,385 $33.4m6.35% 6.35% AddedShares held: Q3 2021 596.3k, Q4 2021 464.2k, Q1 2022 191.0k, Q2 2022 218.4k +27.4k +27,391 14.3%
6 SPDR SER TR S&P BIOTECH XBI XBI 437,748 $32.5m6.17% 6.17% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 437.7k
7 NOVO-NORDISK A S ADR NVO NVO 261,440 $29.1m5.53% 5.53% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 237.4k, Q2 2022 261.4k +24.0k +24,040 10.1%
8 MERCK & CO INC COM MRK MRK 285,000 $26.0m4.93% 4.93% AddedShares held: Q3 2021 0, Q4 2021 346.4k, Q1 2022 278.2k, Q2 2022 285.0k +6.8k +6,800 2.4%
9 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,139,329 $21.9m4.16% 4.16% ReducedShares held: Q3 2021 750.6k, Q4 2021 1.2m, Q1 2022 1.3m, Q2 2022 1.1m -138.1k -138,084 -10.8%
10 ALTIMMUNE INC COM NEW ALT ALT 1,392,884 $16.3m3.09% 3.09% AddedShares held: Q3 2021 1.1m, Q4 2021 1.2m, Q1 2022 1.3m, Q2 2022 1.4m +85.9k +85,931 6.6%
11 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 536,664 $13.2m2.51% 2.51% AddedShares held: Q3 2021 247.9k, Q4 2021 342.6k, Q1 2022 460.0k, Q2 2022 536.7k +76.6k +76,639 16.7%
12 FIVE9 INC COM FIVN FIVN 140,968 $12.8m2.44% 2.44% AddedShares held: Q3 2021 0, Q4 2021 85.6k, Q1 2022 29.7k, Q2 2022 141.0k +111.3k +111,269 374.7%
13 CHINOOK THERAPEUTICS INC COM ADRO ADRO 643,731 $11.3m2.14% 2.14% AddedShares held: Q3 2021 0, Q4 2021 111.7k, Q1 2022 493.7k, Q2 2022 643.7k +150.1k +150,054 30.4%
14 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 586,820 $10.9m2.08% 2.08% AddedShares held: Q3 2021 548.6k, Q4 2021 423.2k, Q1 2022 521.9k, Q2 2022 586.8k +64.9k +64,873 12.4%
15 NICE LTD SPONSORED ADR NICE NICE 55,482 $10.7m2.03% 2.03% NewShares held: Q3 2021 37.8k, Q4 2021 0, Q1 2022 0, Q2 2022 55.5k
16 MERUS N V COM MRUS MRUS 409,161 $9.3m1.76% 1.76% AddedShares held: Q3 2021 309.4k, Q4 2021 341.0k, Q1 2022 409.1k, Q2 2022 409.2k +20 +20 0.0%
17 IVERIC BIO INC COM OPHT OPHT 962,470 $9.3m1.76% 1.76% AddedShares held: Q3 2021 485.0k, Q4 2021 485.0k, Q1 2022 774.1k, Q2 2022 962.5k +188.3k +188,340 24.3%
18 KURA ONCOLOGY INC COM KURA KURA 494,595 $9.1m1.72% 1.72% ReducedShares held: Q3 2021 788.7k, Q4 2021 832.2k, Q1 2022 618.2k, Q2 2022 494.6k -123.6k -123,649 -20.0%
19 RELMADA THERAPEUTICS INC COM RLMD RLMD 466,830 $8.9m1.68% 1.68% AddedShares held: Q3 2021 0, Q4 2021 478.2k, Q1 2022 291.3k, Q2 2022 466.8k +175.6k +175,578 60.3%
20 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,147,878 $8.6m1.64% 1.64% AddedShares held: Q3 2021 832.9k, Q4 2021 832.9k, Q1 2022 832.9k, Q2 2022 1.1m +315.0k +315,000 37.8%
21 AMICUS THERAPEUTICS INC COM FOLD FOLD 753,037 $8.1m1.54% 1.54% NewShares held: Q3 2021 491.2k, Q4 2021 0, Q1 2022 0, Q2 2022 753.0k
22 META PLATFORMS INC CL A META META 50,000 $8.1m1.53% 1.53% NewShares held: Q3 2021 34.4k, Q4 2021 41.6k, Q1 2022 0, Q2 2022 50.0k
23 IMMATICS N.V SHS IMTX IMTX 730,712 $6.4m1.21% 1.21% AddedShares held: Q3 2021 800.0k, Q4 2021 621.9k, Q1 2022 621.9k, Q2 2022 730.7k +108.8k +108,787 17.5%
24 INOZYME PHARMA INC COM COM 1,165,600 $5.6m1.06% 1.06% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.2m
25 C4 THERAPEUTICS INC COM STK CCCC CCCC 705,736 $5.3m1.01% 1.01% AddedShares held: Q3 2021 381.8k, Q4 2021 398.5k, Q1 2022 362.5k, Q2 2022 705.7k +343.2k +343,208 94.7%
26 FIVERR INTL LTD NOTE 11/0 FVRR 0 11.01.25 FVRR 0 11.01.25 4,951,000 $3.8m0.72% 0.72% UnchangedShares held: Q3 2021 0, Q4 2021 13.0m, Q1 2022 5.0m, Q2 2022 5.0m
27 REZOLUTE INC COM NEW RZLT RZLT 1,155,897 $3.7m0.71% 0.71% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.2m
28 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 3,291,135 $2.9m0.55% 0.55% ReducedShares held: Q3 2021 3.8m, Q4 2021 4.0m, Q1 2022 5.0m, Q2 2022 3.3m -1.7m -1,660,288 -33.5%
29 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 679,400 $2.9m0.54% 0.54% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 679.4k
30 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 2,525,000 $2.9m0.54% 0.54% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.5m
31 PMV PHARMACEUTICALS INC COM PMVP PMVP 187,800 $2.7m0.51% 0.51% NewShares held: Q3 2021 190.5k, Q4 2021 190.5k, Q1 2022 0, Q2 2022 187.8k
32 VISA INC COM CL A V V 12,600 $2.5m0.47% 0.47% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 25.2k, Q2 2022 12.6k -12.6k -12,600 -50.0%
33 KEZAR LIFE SCIENCES INC COM COM 299,654 $2.5m0.47% 0.47% AddedShares held: Q3 2021 0, Q4 2021 337.3k, Q1 2022 187.6k, Q2 2022 299.7k +112.1k +112,055 59.7%
34 AIRBNB INC COM CL A ABNB ABNB 27,700 $2.5m0.47% 0.47% ReducedShares held: Q3 2021 0, Q4 2021 47.7k, Q1 2022 30.0k, Q2 2022 27.7k -2.3k -2,300 -7.7%
35 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 597,003 $2.4m0.46% 0.46% AddedShares held: Q3 2021 688.5k, Q4 2021 648.4k, Q1 2022 584.2k, Q2 2022 597.0k +12.8k +12,800 2.2%
36 INVESCO QQQ TR UNIT SER 1 QQQ QQQ 8,186 $2.3m0.44% 0.44% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 8.2k
37 KEROS THERAPEUTICS INC COM KROS KROS 67,997 $1.9m0.36% 0.36% ReducedShares held: Q3 2021 0, Q4 2021 119.7k, Q1 2022 139.6k, Q2 2022 68.0k -71.6k -71,584 -51.3%
38 NVIDIA CORPORATION COM NVDA NVDA 11,288 $1.7m0.32% 0.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 11.3k
39 89BIO INC COM ETNB ETNB 450,000 $1.4m0.28% 0.28% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 450.0k
40 MAGIC SOFTWARE ENTERPRISES L ORD MGIC MGIC 81,293 $1.4m0.27% 0.27% UnchangedShares held: Q3 2021 57.7k, Q4 2021 57.7k, Q1 2022 81.3k, Q2 2022 81.3k
41 ADVANCED MICRO DEVICES INC COM AMD AMD 15,773 $1.2m0.23% 0.23% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 15.8k -84.2k -84,227 -84.2%
42 KINNATE BIOPHARMA INC COM KNTE KNTE 91,673 $1.2m0.22% 0.22% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 91.7k
43 ONCORUS INC COM COM 540,258 $681.0k0.13% 0.13% UnchangedShares held: Q3 2021 880.7k, Q4 2021 571.2k, Q1 2022 540.3k, Q2 2022 540.3k
44 NICE SYS INC NOTE 1.250% 1/1 NICEIT 1.25 01.15.24 NICEIT 1.25 01.15.24 250,000 $588.0k0.11% 0.11% UnchangedShares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
45 WIX COM LTD NOTE 8/1 WIX 0 08.15.25 WIX 0 08.15.25 700,000 $566.0k0.11% 0.11% NewShares held: Q3 2021 11.1m, Q4 2021 19.0m, Q1 2022 0, Q2 2022 700.0k
46 GENERAC HLDGS INC COM GNRC GNRC 2,310 $486.0k0.09% 0.09% ReducedShares held: Q3 2021 71.0k, Q4 2021 42.1k, Q1 2022 42.2k, Q2 2022 2.3k -39.9k -39,901 -94.5%
47 OTONOMO TECHNOLOGIES LTD ORDINARY SHARES ORDINARY SHARES 391,863 $431.0k0.08% 0.08% UnchangedShares held: Q3 2021 600.0k, Q4 2021 593.6k, Q1 2022 391.9k, Q2 2022 391.9k
48 ARBE ROBOTICS LTD ORDINARY SHARES ARBE ARBE 43,165 $237.0k0.04% 0.04% UnchangedShares held: Q3 2021 0, Q4 2021 120.4k, Q1 2022 43.2k, Q2 2022 43.2k
49 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 100,000 $204.0k0.04% 0.04% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
50 VINCERX PHARMA INC COM NEW COM NEW 70,467 $93.0k0.02% 0.02% ReducedShares held: Q3 2021 654.6k, Q4 2021 720.2k, Q1 2022 720.2k, Q2 2022 70.5k -649.7k -649,694 -90.2%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
PFIZER INC PFE PFE 515,070 $26.7m515.1k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 211,326 $16.3m211.3k shares
KYMERA THERAPEUTICS INC KYMR KYMR 368,061 $15.6m368.1k shares
ZIM INTEGRATED SHIPPING SERV ZIM ZIM 148,000 $10.8m148.0k shares
PERION NETWORK LTD PERI PERI 306,051 $6.9m306.1k shares
IMMUNIC INC 583,206 $6.6m583.2k shares
SUNRUN INC RUN RUN 150,000 $4.6m150.0k shares
CAESARSTONE LTD CSTE CSTE 428,046 $4.5m428.0k shares
MASTERCARD INCORPORATED MA MA 12,100 $4.3m12.1k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 24,768 $4.0m24.8k shares
NAUTILUS BIOTECHNOLOGY INC NAUT NAUT 840,000 $3.6m840.0k shares
REPLIMUNE GROUP INC REPL REPL 212,640 $3.6m212.6k shares
FATE THERAPEUTICS INC FATE FATE 89,425 $3.5m89.4k shares
VERONA PHARMA PLC VRNA VRNA 666,339 $3.3m666.3k shares
ASCENDIS PHARMA A/S 26,529 $3.1m26.5k shares
IRONSOURCE LTD IS5EUR IS5EUR 620,000 $3.0m620.0k shares
CATERPILLAR INC CAT CAT 12,000 $2.7m12.0k shares
SENTINELONE INC S S 65,000 $2.5m65.0k shares
KRYSTAL BIOTECH INC KRYS KRYS 25,310 $1.7m25.3k shares
CYCLACEL PHARMACEUTICALS INC 508,322 $1.6m508.3k shares
LIANBIO LIANY LIANY 275,007 $1.0m275.0k shares
AYALA PHARMACEUTICALS INC 250,000 $995.0k250.0k shares
OUTBRAIN INC TEAD TEAD 52,531 $564.0k52.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Call QQQCall 992,800 $278.3m992.8k shares New
SPDR S&P 500 ETF TR SPY · Call SPYCall 199,500 $75.3m199.5k shares New
TEVA PHARMACEUTICAL INDS LTD Call Call 3,381,600 $25.4m3.4m shares Added
SPDR SER TR XBI · Call XBICall 200,000 $14.9m200.0k shares New
ALNYLAM PHARMACEUTICALS INC ALNY · Call ALNYCall 75,000 $10.9m75.0k shares New
IVERIC BIO INC OPHT · Call OPHTCall 200,000 $1.9m200.0k shares New
VISTAGEN THERAPEUTICS INC VTGN · Call VTGNCall 1,500,000 $1.3m1.5m shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13